DnB Asset Management
RDY icon

DnB Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

DnB Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-241,520
Closed -$2.24M – 538
2015
Q4 		$2.24M Sell
241,520
-19,155
-7% -$210K 0.05% 222
2015
Q3 		$3.33M Buy
260,675
+30,000
+13% +$373K 0.08% 165
2015
Q2 		$2.55M Buy
230,675
+8,000
+4% +$88.3K 0.06% 197
2015
Q1 		$2.54M Sell
222,675
-3,825
-2% -$40.6K 0.06% 203
2014
Q4 		$2.29M Sell
226,500
-163,500
-42% -$1.72M 0.05% 210
2014
Q3 		$4.1M Buy
390,000
+3,500
+0.9% +$32.9K 0.09% 154
2014
Q2 		$3.34M Buy
+386,500
New +$3.25M 0.07% 175
2013
Q4 		$1.04M Sell
126,500
-33,000
-21% -$261K 0.02% 240
2013
Q3 		$1.21M Sell
159,500
-146,000
-48% -$1.06M 0.03% 232
2013
Q2 		$2.31M Buy
+305,500
New +$2.23M 0.07% 130

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

DnB Asset Management's RDY Position: Q1 2016 in Review

DnB Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2016, closing a stake of 241,520 shares — an estimated $2.24M sold.

DnB Asset Management first reported a position in RDY in Q2 2013 and held it in 10 quarters. The position peaked at $4.1M in Q3 2014. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

  • DnB Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2016 after selling out during the quarter.
  • DnB Asset Management sold 241,520 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $2.24M.
  • DnB Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 10 quarters.
  • DnB Asset Management's Dr. Reddy's Laboratories position peaked at $4.1M in Q3 2014.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on DnB Asset Management's 13F filing for Q1 2016, filed 11 Apr 2016.